{"id":"W2015291056","doi":"10.1258/0956462001915732","title":"Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010)","year":2000,"lang":"en","type":"article","venue":"International Journal of STD & AIDS","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"HIV Legal Network","funders":"","keywords":"Medicine; Internal medicine; Randomized controlled trial; Ethambutol; Population; Rifabutin; Clofazimine; Chills; Clarithromycin; Physical therapy; Tuberculosis; Immunology; Rifampicin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00119135,0.00009846911,0.0004863442,0.0003503449,0.00004472306,0.00008938151,0.0001376642,0.00003193834,0.001020903],"category_scores_gemma":[0.0003001015,0.0000522047,0.0001653012,0.00007386757,0.00006011956,0.00009541053,0.000006523981,0.0001628421,0.0000128345],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006016232,"about_ca_system_score_gemma":0.0009526578,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.06974778,"about_ca_topic_score_gemma":0.02922833,"domain_scores_codex":[0.9983211,0.0002235024,0.0005247524,0.0000788406,0.0006146487,0.0002371552],"domain_scores_gemma":[0.9988385,0.0004800302,0.0001311943,0.00008527997,0.0001257133,0.0003392775],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3180214,0.001252619,0.4188074,0.00003139102,0.001807599,0.001101747,0.004296144,0.00001269017,0.00001697386,0.0009107392,0.002774992,0.2509664],"study_design_scores_gemma":[0.7228801,0.003550366,0.2624256,0.0002063716,0.00008086061,0.0003662797,0.0002584199,0.00008749723,0.00002060243,0.0006245063,0.009411067,0.00008832732],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9726251,0.0004982668,0.000003474756,0.02428018,0.0002350233,0.0005476024,0.00002637787,0.000002814396,0.001781188],"genre_scores_gemma":[0.9945112,0.002614899,0.0002550631,0.001987359,0.0002713217,0.00002569813,0.00001104517,0.000006469745,0.0003169418],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4048587,"threshold_uncertainty_score":0.9998923,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03517055905874528,"score_gpt":0.3764483563666937,"score_spread":0.3412777973079484,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}